Sina Naserian

1.2k citations
35 papers · 888 indexed · h-index 19
Topics
Mesenchymal stem cell research (12 papers)Angiogenesis and VEGF in Cancer (8 papers)Immune Cell Function and Interaction (7 papers)
Partner nations
FranceIranEgypt

In The Last Decade

Sina Naserian

34 papers receiving 872 citations

Peers

Sina Naserian
Comparison fields: 5 of 84
  • Immunology 343
  • Molecular Biology 314
  • Genetics 243
  • Surgery 168
  • Oncology 149
Replace Hélder Trindade with:
Hélder Trindade Portugal
Raghavan Chinnadurai United States
Lisa O’Flynn Ireland
Chih‐Pin Liu United States
Hui‐Sheng Ai China
S Witte Netherlands
Shengnan Zhao China
Tanja Strini Netherlands
Mario Ricciardi Italy
Michelle M. Duffy Ireland
Sina Naserian relative to Hélder Trindade Portugal Hélder Trindade's profile →
Citations per field
00.5×2.7×
Hélder Trindade · 1×
Citations per year

Countries citing papers authored by Sina Naserian

Since Specialization
Citations

This map shows the geographic impact of Sina Naserian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sina Naserian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sina Naserian more than expected).

Fields of papers citing papers by Sina Naserian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sina Naserian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sina Naserian. The network helps show where Sina Naserian may publish in the future.

Co-authorship network of co-authors of Sina Naserian

This figure shows the co-authorship network connecting the top 25 collaborators of Sina Naserian. A scholar is included among the top collaborators of Sina Naserian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sina Naserian. Sina Naserian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 4
2 7
3 19
4 17
5 46
6 24
7 25
8 23
9 43
10 35
11 18
12 5
13 78
14 58
15 75
16 34
17 18
18 30
19 26
20 90

About Sina Naserian

Sina Naserian is a scholar working on Genetics, Business and International Management and Immunology, having authored 35 papers that have together received 888 indexed citations. Recurring topics across this work include Mesenchymal stem cell research (12 papers), Angiogenesis and VEGF in Cancer (8 papers) and Immune Cell Function and Interaction (7 papers). The work is most often cited by research in Genetics (243 citations), Immunology (343 citations) and Hematology (107 citations). Sina Naserian has collaborated with scholars based in France, Iran and Egypt. Frequent co-authors include Georges Uzan, Sara Shamdani, José L. Cohen, Mohamed Essameldin Abdelgawad, Maryam Khosravi, Nassim Arouche, Benoı̂t L. Salomon, Negar Azarpira, Caroline Pilon and Mohammad Hossein Karimi. Their work appears in journals such as Blood, Scientific Reports and International Journal of Molecular Sciences.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026